Cooper B - Search Results

1

Concurrent blinatumomab and donor lymphocyte infusions for treatment of relapsed pre-B-cell ALL after allogeneic hematopoietic cell transplant.

Ueda M, de Lima M, Caimi P, Tomlinson B, Little J, Creger R, Lazarus H, Cooper B. Ueda M, et al. Among authors: cooper b. Bone Marrow Transplant. 2016 Sep;51(9):1253-5. doi: 10.1038/bmt.2016.104. Epub 2016 Apr 18. Bone Marrow Transplant. 2016. PMID: 27088374 No abstract available.

2

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.

Lazarus HM, Crilley P, Ciobanu N, Creger RJ, Fox RM, Shina DC, Bulova SI, Gucalp R, Cooper BW, Topolsky D, et al. Lazarus HM, et al. Among authors: cooper bw. J Clin Oncol. 1992 Nov;10(11):1682-9. doi: 10.1200/JCO.1992.10.11.1682. J Clin Oncol. 1992. PMID: 1403051 Clinical Trial.

3

Combined therapy with rG-CSF and GM-CSF for the mobilization of hematopoietic progenitor cells.

Winter JN, Mangan C, Bryd K, Tallman M, Gordon L, Jahnke L, Lazarus H, Cooper B, Crum E, Horvath N, et al. Winter JN, et al. Among authors: cooper b. Prog Clin Biol Res. 1994;389:463-70. Prog Clin Biol Res. 1994. PMID: 7535455 Clinical Trial. No abstract available.

4

Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer.

Lazarus HM, Winton EF, Williams SF, Grinblatt D, Campion M, Cooper BW, Gunn H, Manfreda S, Isaacs RE. Lazarus HM, et al. Among authors: cooper bw. Bone Marrow Transplant. 1995 Jun;15(6):935-42. Bone Marrow Transplant. 1995. PMID: 7581094 Clinical Trial.

5

Acute cholecystitis after autologous bone marrow transplantation for acute myeloid leukemia.

Kuttah L, Weber F, Creger RJ, Fox RM, Cooper BW, Jacobs G, Lazarus HM. Kuttah L, et al. Among authors: cooper bw. Ann Oncol. 1995 Mar;6(3):302-4. doi: 10.1093/oxfordjournals.annonc.a059163. Ann Oncol. 1995. PMID: 7612498 Free article.

6

Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.

Fields KK, Elfenbein GJ, Lazarus HM, Cooper BW, Perkins JB, Creger RJ, Ballester OF, Hiemenz JH, Janssen WE, Zorsky PE. Fields KK, et al. Among authors: cooper bw. J Clin Oncol. 1995 Feb;13(2):323-32. doi: 10.1200/JCO.1995.13.2.323. J Clin Oncol. 1995. PMID: 7844593 Clinical Trial.

7

Hepatic dysfunction in patients with carcinoma who are severely thrombocytopenic and immunosuppressed.

Lazarus HM, Creger RJ, Fox RM, Cooper BW, Jacobs G, Stellato TA. Lazarus HM, et al. Among authors: cooper bw. J Am Coll Surg. 1994 Oct;179(4):433-9. J Am Coll Surg. 1994. PMID: 7921393

8

Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic stem cell transplantation: effect of aminoglycoside therapy.

Cooper BW, Creger RJ, Soegiarso W, Mackay WL, Lazarus HM. Cooper BW, et al. Am J Med. 1993 May;94(5):497-504. doi: 10.1016/0002-9343(93)90084-3. Am J Med. 1993. PMID: 8098904

9

An inflammatory eruption associated with recombinant human IL-6.

Fleming TE, Mirando WS, Soohoo LF, Cooper BW, Zaim MT, Lazarus HM, Elmets CA. Fleming TE, et al. Among authors: cooper bw. Br J Dermatol. 1994 Apr;130(4):534-6. doi: 10.1111/j.1365-2133.1994.tb03393.x. Br J Dermatol. 1994. PMID: 8186125

10

Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies.

Crilley P, Lazarus H, Topolsky D, Ciobanu N, Creger RJ, Fox RM, Bulova SI, Shina DC, Gucalp R, Cooper BW, et al. Crilley P, et al. Among authors: cooper bw. Semin Oncol. 1993 Aug;20(4 Suppl 4):50-4; quiz 55. Semin Oncol. 1993. PMID: 8342076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,791 results

Search Page

Filters